Literature DB >> 29107630

Surgical hand preparation with chlorhexidine soap or povidone iodine: new methods to increase immediate and residual effectiveness, and provide a safe alternative to alcohol solutions.

R Herruzo1, M J Vizcaino2, R Yela2.   

Abstract

BACKGROUND: Surgical use of 4% chlorhexidine soap (CHX-4) and 10% povidone iodine (PVP-I-10) does not meet the standards defined by EN 12791. AIM: To investigate the possibility of increasing the immediate and residual effects of these antiseptics.
METHODS: Over three consecutive weeks, n-propanol, standard CHX-4 and PVP-I-10 were tested in two experimental groups of volunteers. The new method for applying the antiseptic substances involved standard hand rub and rinse of CHX-4 or PVP-I-10, followed by application of an aqueous solution based on 5% chlorhexidine or PVP-I-10 with no further rinsing of the hands prior to donning gloves. Samples were taken to assess immediate and residual effects, analysing the logarithmic reduction of colony-forming units.
FINDINGS: At t=0 h, n-propanol was superior in bactericidal effect to standard CHX-4 (P<0.05), but the new chlorhexidine protocol was superior to both standard CHX-4 (P<0.01) and n-propanol (P<0.05); the same effect was observed at t=3 h (residual effect). At t=0 h, n-propanol was significantly superior to standard PVP-I-10, but the new PVP-I-10 protocol was superior, although not significantly, to n-propanol. There was no significant residual effect at t=3 h.
CONCLUSION: The new protocol for chlorhexidine application permits surgical hand preparation with chlorhexidine, as a safe alternative to alcohol solutions, because it meets the standards defined by EN 12791.
Copyright © 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aqueous chlorhexidine; Chlorhexidine soap; EN 12791; Residual effect

Mesh:

Substances:

Year:  2017        PMID: 29107630     DOI: 10.1016/j.jhin.2017.10.021

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  2 in total

Review 1.  Infectious Disease Management and Control with Povidone Iodine.

Authors:  Maren Eggers
Journal:  Infect Dis Ther       Date:  2019-08-14

2.  In Response: 'Perioperative COVID-19 Defense: An Evidence-Based Approach for Optimization of Infection Control and Operating Room Management'.

Authors:  Randy W Loftus; Franklin Dexter; Michelle C Parra; Jeremiah R Brown
Journal:  Anesth Analg       Date:  2020-07       Impact factor: 6.627

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.